Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Aventis Pharma Limited, trading as Sanofi, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, United Kingdom
Dulcolax Pico Liquid, 5 mg/5 ml, oral solution.
| Pharmaceutical Form |
|---|
|
Oral solution. Clear, colourless to yellowish or slightly yellowish-brown, slightly viscous liquid. |
Each 5ml of liquid contains 5 mg sodium picosulfate.
Dulcolax Pico Liquid also contains methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216) and ethanol.
For full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Sodium picosulfate |
Sodium picosulfate is a locally acting laxative from the triarylmethane group, which after bacterial cleavage in the colon, has a dual-action with stimulation of the mucosa of both the large intestine and of the rectum. |
| List of Excipients |
|---|
|
Sodium carboxymethylcellulose |
Amber glass bottles with aluminium ROPP caps.
Pack sizes of 90 and 500 ml.
Amber glass bottles with polypropylene tamper-evident closure with expanded polyethylene (coated with LDPE) liner.
Pack sizes of 100, 250 and 300 ml.
Not all pack sizes may be marketed.
Aventis Pharma Limited, trading as Sanofi, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, United Kingdom
PL 04425/0714
16/09/2005
| Drug | Countries | |
|---|---|---|
| DULCOLAX PICO | Ireland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
